Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Tertiary lymphoid structures (TLS) in tumors are linked to improved patient prognosis and response to immune checkpoint inhibitors, particularly in non-small cell lung cancer.
• The precise mechanisms of TLS formation, composition, and immune regulation are still under investigation.
• A key challenge is leveraging TLS to amplify anti-tumor immune responses, both spontaneous and treatment-induced.

Purpose of the Study:

• To review the current understanding of tumor-associated TLS.
• To discuss preclinical models for studying TLS.
• To explore therapeutic strategies for enhancing TLS in cancer, with a focus on lung cancer.

Main Methods:

• Literature review and synthesis of current research on TLS in cancer.
• Discussion of established and emerging preclinical models for TLS investigation.
• Analysis of potential therapeutic interventions targeting TLS formation and function.

Main Results:

• TLS are associated with favorable clinical outcomes and immunotherapy response in various cancers, including lung cancer.
• Preclinical and clinical studies are progressively clarifying the roles of TLS in antitumor immunity.
• Significant challenges persist in therapeutically exploiting TLS to augment immune responses against tumors.

Conclusions:

• Understanding TLS biology is crucial for improving cancer immunotherapy.
• Targeting TLS represents a promising avenue for enhancing treatment efficacy in lung cancer.
• Further research into TLS modulation is warranted to optimize cancer treatment strategies.